• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice.在人类白细胞抗原DR3(DRB1*0301)转基因II类敲除非肥胖糖尿病小鼠中,CD4+CD25+调节性T细胞的耗竭会加剧碘化钠诱导的实验性自身免疫性甲状腺炎。
Clin Exp Immunol. 2007 Mar;147(3):547-54. doi: 10.1111/j.1365-2249.2006.03303.x.
2
Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis.易感性和抗性HLA-II类转基因在小鼠实验性自身免疫性甲状腺炎中的共表达:DQ8分子下调DR3介导的甲状腺炎。
J Autoimmun. 2002 May;18(3):213-20. doi: 10.1006/jaut.2002.0587.
3
HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible.人甲状腺球蛋白诱导的自身免疫性甲状腺炎中的HLA - DR和HLA - DQ多态性:DR3和DQ8转基因小鼠易感。
Hum Immunol. 2002 Apr;63(4):301-10. doi: 10.1016/s0198-8859(02)00360-9.
4
Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice.非肥胖糖尿病小鼠实验性自身免疫性甲状腺炎中TCR库的灵活性及HLA-DR3分子的易感性
J Autoimmun. 2001 Aug;17(1):7-15. doi: 10.1006/jaut.2001.0528.
5
Application of HLA class II transgenic mice to study autoimmune regulation.HLA II类转基因小鼠在自身免疫调节研究中的应用。
Thyroid. 2007 Oct;17(10):995-1003. doi: 10.1089/thy.2007.0196.
6
HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease.用于研究自身免疫性甲状腺疾病易感性和保护性的HLA和H2 II类转基因小鼠模型。
Autoimmunity. 2003 Sep-Nov;36(6-7):397-404. doi: 10.1080/08916930310001603028.
7
Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice.在 HLA - DRB1*0301(DR3)转基因小鼠中复制人类甲状腺自身免疫时,甲状腺过氧化物酶 DNA 免疫相较于蛋白质免疫的优越性。
Clin Exp Immunol. 2004 Sep;137(3):503-12. doi: 10.1111/j.1365-2249.2004.02553.x.
8
New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models.利用H2和HLA II类转基因模型在自身免疫性甲状腺炎易感性方面的新发现。
Int Rev Immunol. 2000;19(6):573-85. doi: 10.3109/08830180009088513.
9
CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice.在NOD-H2h4小鼠中,CD4+CD25+自然产生的调节性T细胞而非淋巴细胞减少在碘诱导的自身免疫性甲状腺炎发病机制中起作用。
J Autoimmun. 2007 Sep-Nov;29(2-3):195-202. doi: 10.1016/j.jaut.2007.07.008. Epub 2007 Sep 10.
10
Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen.天然存在的CD4(+)CD25(+)Foxp3(+)调节性T细胞对于由外源性或内源性自身抗原诱导的实验性自身免疫性甲状腺炎的耐受性是必需的。
J Autoimmun. 2009 Aug;33(1):68-76. doi: 10.1016/j.jaut.2009.03.010. Epub 2009 Apr 17.

引用本文的文献

1
CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients.乳腺癌患者中的CD4+CD25(高表达)、CD8+CD28-细胞及甲状腺自身抗体
Cent Eur J Immunol. 2014;39(3):338-44. doi: 10.5114/ceji.2014.45945. Epub 2014 Oct 14.
2
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.打破对甲状腺抗原的耐受性:甲状腺自身免疫中概念的改变。
Endocr Rev. 2014 Feb;35(1):59-105. doi: 10.1210/er.2013-1055. Epub 2013 Dec 4.
3
Circulating lymphocyte subsets and regulatory T cells in patients with postpartum thyroiditis during the first postpartum year.产后第一年患产后甲状腺炎患者的循环淋巴细胞亚群和调节性T细胞
Clin Exp Med. 2009 Dec;9(4):263-7. doi: 10.1007/s10238-009-0046-0. Epub 2009 May 6.
4
Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.自身免疫性甲状腺炎作为癌症免疫治疗期间自身免疫后遗症的指标。
Autoimmun Rev. 2009 Sep;9(1):28-33. doi: 10.1016/j.autrev.2009.02.034. Epub 2009 Feb 28.
5
Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells.肿瘤坏死因子相关凋亡诱导配体通过扩增CD4+CD25+调节性T细胞抑制实验性自身免疫性甲状腺炎。
Endocrinology. 2009 Apr;150(4):2000-7. doi: 10.1210/en.2008-1389. Epub 2008 Nov 13.
6
Establishing humanized mice using stem cells: maximizing the potential.利用干细胞建立人源化小鼠:最大化其潜能。
Clin Exp Immunol. 2008 Jun;152(3):406-14. doi: 10.1111/j.1365-2249.2008.03659.x. Epub 2008 Apr 24.

本文引用的文献

1
Experimental autoimmune thyroiditis in the mouse.小鼠实验性自身免疫性甲状腺炎
Curr Protoc Immunol. 2007 Aug;Chapter 15:15.7.1-15.7.21. doi: 10.1002/0471142735.im1507s78.
2
Iodination of tyrosyls in thyroglobulin generates neoantigenic determinants that cause thyroiditis.甲状腺球蛋白中酪氨酸残基的碘化会产生导致甲状腺炎的新抗原决定簇。
J Immunol. 2006 Apr 1;176(7):4479-83. doi: 10.4049/jimmunol.176.7.4479.
3
B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis.缺乏B细胞的NOD.H-2h4小鼠具有CD4+CD25+调节性T细胞,这些细胞可抑制自发性自身免疫性甲状腺炎的发展。
J Exp Med. 2006 Feb 20;203(2):349-58. doi: 10.1084/jem.20051438. Epub 2006 Jan 30.
4
Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2 mouse.小鼠甲状腺球蛋白的碘化增强了NOD.H2小鼠的自身免疫反应性。
Clin Exp Immunol. 2005 Nov;142(2):251-9. doi: 10.1111/j.1365-2249.2005.02908.x.
5
Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.在CD4+ CD25+调节性T细胞耗竭的小鼠中同时诱导抗肿瘤免疫和自身免疫性甲状腺炎。
Cancer Res. 2005 Sep 15;65(18):8471-8. doi: 10.1158/0008-5472.CAN-05-0934.
6
H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis.源自H2A和H2E的CD4+CD25+调节性T细胞:在自身免疫性甲状腺炎中II类基因相互抑制中的潜在作用。
J Immunol. 2005 Mar 1;174(5):3111-6. doi: 10.4049/jimmunol.174.5.3111.
7
Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice.NOD.H-2h4小鼠中碘诱导的甲状腺炎与抗体介导的甲状腺功能亢进之间的分离。
Endocrinology. 2005 Jan;146(1):294-300. doi: 10.1210/en.2004-1126. Epub 2004 Sep 30.
8
Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.自然产生的CD4+调节性T细胞用于免疫自我耐受和免疫反应的负调控。
Annu Rev Immunol. 2004;22:531-62. doi: 10.1146/annurev.immunol.21.120601.141122.
9
CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis.CD137信号传导在诱导实验性自身免疫性甲状腺炎耐受过程中干扰CD4+CD25+调节性T细胞的活化和功能。
Cell Immunol. 2003 Nov;226(1):20-9. doi: 10.1016/j.cellimm.2003.11.002.
10
High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece.希腊西北部消除碘缺乏症后学龄儿童自身免疫性甲状腺炎的高患病率。
Thyroid. 2003 May;13(5):485-9. doi: 10.1089/105072503322021151.

在人类白细胞抗原DR3(DRB1*0301)转基因II类敲除非肥胖糖尿病小鼠中,CD4+CD25+调节性T细胞的耗竭会加剧碘化钠诱导的实验性自身免疫性甲状腺炎。

Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice.

作者信息

Flynn J C, Meroueh C, Snower D P, David C S, Kong Y M

机构信息

Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

出版信息

Clin Exp Immunol. 2007 Mar;147(3):547-54. doi: 10.1111/j.1365-2249.2006.03303.x.

DOI:10.1111/j.1365-2249.2006.03303.x
PMID:17302906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1810500/
Abstract

Both genetic and environmental factors contribute to autoimmune disease development. Previously, we evaluated genetic factors in a humanized mouse model of Hashimoto's thyroiditis (HT) by immunizing human leucocyte antigen DR3 (HLA-DR3) and HLA-DQ8 transgenic class II-knock-out non-obese diabetic (NOD) mice. DR3+ mice were susceptible to experimental autoimmune thyroiditis (EAT) induction by both mouse thyroglobulin (mTg) and human (h) Tg, while DQ8+ mice were weakly susceptible only to hTg. As one environmental factor associated with HT and tested in non-transgenic models is increased sodium iodide (NaI) intake, we examined the susceptibility of DR3+ and/or DQ8+ mice to NaI-induced disease. Mice were treated for 8 weeks with NaI in the drinking water. At 0 x 05% NaI, 23% of DR3+, 0% of DQ8+ and 20% of DR3+DQ8+ mice had thyroid destruction. No spleen cell proliferation to mTg was observed. Most mice had undetectable anti-mTg antibodies, but those with low antibody levels usually had thyroiditis. At 0.3% NaI, a higher percentage of DR3+ and DR3+DQ8+ mice developed destructive thyroiditis, but it was not statistically significant. However, when DR3+ mice had been depleted of CD4+CD25+ regulatory T cells prior to NaI treatment, destructive thyroiditis (68%) and serum anti-mTg antibodies were exacerbated further. The presence of DQ8 molecules does not alter the susceptibility of DR3+DQ8+ mice to NaI-induced thyroiditis, similar to earlier findings with mTg-induced EAT. Susceptibility of DR3+ mice to NaI-induced EAT, in both the presence and absence of regulatory T cells, demonstrates the usefulness of HLA class II transgenic mice in evaluating the roles of environmental factors and immune dysregulation in autoimmune thyroid disease.

摘要

遗传因素和环境因素均会促使自身免疫性疾病的发展。此前,我们通过免疫人白细胞抗原DR3(HLA-DR3)和HLA-DQ8转基因II类敲除非肥胖糖尿病(NOD)小鼠,在桥本甲状腺炎(HT)的人源化小鼠模型中评估了遗传因素。DR3+小鼠对小鼠甲状腺球蛋白(mTg)和人(h)Tg诱导的实验性自身免疫性甲状腺炎(EAT)均易感,而DQ8+小鼠仅对hTg有较弱的易感性。作为一种与HT相关且在非转基因模型中进行过测试的环境因素,碘化钠(NaI)摄入量增加,我们研究了DR3+和/或DQ8+小鼠对NaI诱导疾病的易感性。给小鼠饮用含NaI的水8周。在0.05% NaI时,23%的DR3+小鼠、0%的DQ8+小鼠和20%的DR3+DQ8+小鼠出现甲状腺破坏。未观察到脾细胞对mTg的增殖。大多数小鼠未检测到抗mTg抗体,但抗体水平低的小鼠通常患有甲状腺炎。在0.3% NaI时,更高比例的DR3+和DR3+DQ8+小鼠发生了破坏性甲状腺炎,但差异无统计学意义。然而,当DR3+小鼠在NaI处理前耗尽CD4+CD25+调节性T细胞时,破坏性甲状腺炎(68%)和血清抗mTg抗体进一步加重。与早期mTg诱导的EAT研究结果相似,DQ8分子的存在并未改变DR3+DQ8+小鼠对NaI诱导的甲状腺炎的易感性。无论是否存在调节性T细胞,DR3+小鼠对NaI诱导的EAT的易感性都证明了HLA II类转基因小鼠在评估环境因素和免疫失调在自身免疫性甲状腺疾病中的作用方面的实用性。